Epilepsy Treatment Insurance Claim Denied? How to Appeal

An epilepsy treatment denial is never just an administrative inconvenience. Uncontrolled seizures carry serious consequences: elevated SUDEP (Sudden Unexpected Death in Epilepsy) risk, driving restrictions requiring a seizure-free period of three to twelve months depending on state law, injury from falls, and lost employment. Yet fewer than 1% of patients who receive a denial actually appeal. The process costs nothing, and appeals succeed at meaningful rates — External Independent Review: Complete Guide" class="auto-link">external reviewers overturn insurer denials approximately 40 to 60 percent of the time.

Why Insurers Deny Epilepsy Treatment Claims

Not medically necessary. The insurer's utilization reviewer determined the treatment does not meet its internal clinical criteria, often using review tools like Milliman or InterQual that are more restrictive than American Academy of Neurology (AAN) guidelines. These criteria are the insurer's own — not medical standards.

Step therapy required. The insurer requires patients to try older, less expensive treatments before approving newer interventions. The International League Against Epilepsy (ILAE) defines drug-resistant epilepsy (DRE) as failure of two or more adequate AED trials. Once that threshold is met, continued step-therapy requirements are clinically unjustifiable and directly challengeable in an appeal.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained or expired. Many epilepsy medications and procedures — brand-name AEDs, VNS therapy, surgical evaluations — require prior authorization. Lapsed or missing authorization is a common and often correctable denial reason.

Experimental or investigational. Newer treatments including some FDA-approved medications and devices are sometimes denied as experimental. Treatments with AAN guideline support and published clinical trial data can be directly challenged on this ground.

Insufficient documentation. Medical records did not adequately establish medical necessity under the insurer's criteria. Accurate ICD-10 G40.x coding is essential: intractable codes such as G40.019 and G40.119 signal DRE severity to reviewers, while G40.311 signals Lennox-Gastaut syndrome and G40.42 signals Dravet syndrome.

How to Appeal

Step 1: Decode the Denial and Request the Clinical Policy Bulletin

Read your denial letter and identify the exact reason code and policy provision cited. Immediately request the insurer's clinical policy bulletin (CPB) — you are legally entitled to this under ERISA 29 CFR § 2560.503-1 and ACA 45 CFR § 147.136. This document specifies exactly what criteria must be demonstrated to obtain coverage.

Step 2: Establish the Clinical Case with Your Neurologist

Your neurologist's letter is the most powerful document in the appeal. It should state your ICD-10 G40.x intractable diagnosis code, document all prior AED trials with dates and outcomes, explicitly apply ILAE DRE criteria if applicable, explain why the denied treatment is medically necessary for your specific seizure type, cite relevant AAN guidelines, and address the SUDEP risk associated with inadequate seizure control.

Step 3: Address Each Denial Reason Directly

For step-therapy denials: demonstrate prior AED failures satisfy ILAE DRE criteria and that requiring additional failures poses safety risks. For experimental denials: cite AAN guidelines, FDA approval, and published trial data (REDUCE for cenobamate, GWCARE1 for Epidiolex, SANTE for DBS, PACE for VNS). For documentation denials: submit comprehensive records with explicit medical necessity language and ICD-10 intractable coding.

Step 4: Request Peer-to-Peer Review

Ask your neurologist to speak directly with the insurer's medical director. Many epilepsy denials are issued by non-neurologist reviewers — a specialist-to-specialist conversation frequently resolves these cases before further escalation.

Step 5: Submit and Track

Send your appeal via certified mail and through the insurer's portal. Keep all delivery confirmations. Note the insurer's response deadline — 30 days for pre-service, 60 days for post-service under ACA regulations; 72 hours for expedited urgent appeals under 45 CFR § 147.136. A missed insurer deadline triggers deemed exhaustion, giving you the right to proceed directly to external review.

Step 6: Escalate if Denied

Request free external review under the ACA. Request a peer-to-peer review if not yet attempted. File a complaint with your state department of insurance. For ERISA employer plans, consult an attorney about federal court review under ERISA § 502(a)(1)(B) — the administrative record built during the internal appeal is the foundation for any federal court case.

What to Include in Your Appeal

• Denial letter with the specific reason code and policy provision cited
• Neurologist's letter citing ICD-10 G40.x intractable diagnosis and AAN guidelines
• Complete AED treatment history: each drug, dose, duration, and reason discontinued
• ILAE DRE criteria documentation if applicable (failure of two or more adequate AED trials)
• Published clinical trial data if the denial cites experimental grounds
• Documentation of seizure impact: frequency, severity, SUDEP risk, driving restrictions, employment effects

Fight Back With ClaimBack

Epilepsy treatment appeals succeed when they combine accurate clinical documentation with precise legal arguments. ClaimBack generates a professional appeal letter in 3 minutes, citing AAN guidelines, ICD-10 G40.x intractable diagnosis codes, ILAE drug-resistant epilepsy criteria, and the specific regulations that apply to your plan type. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal